[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …

M Brisson, É Bénard, M Drolet, JA Bogaards… - The Lancet Public …, 2016 - thelancet.com
Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Cervical cancer in Nepal: Current screening strategies and challenges

M Narasimhamurthy, SU Kafle - Frontiers in Public Health, 2022 - frontiersin.org
Nepal has a high burden of cervical cancer primarily due to a limited screening program.
Most present with advanced cervical disease. Despite no national cervical cancer control …

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …

JB Lew, KT Simms, MA Smith, M Hall… - The Lancet Public …, 2017 - thelancet.com
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

JE Tota, J Bentley, J Blake, F Coutlée, MA Duggan… - Preventive …, 2017 - Elsevier
Since being introduced in the 1940s, cervical cytology–despite its limitations–has had
unequivocal success in reducing cervical cancer burden in many countries. However, we …

[HTML][HTML] The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC …

HC Kitchener, K Canfell, C Gilham… - Health Technology …, 2014 - ncbi.nlm.nih.gov
BACKGROUND The ARTISTIC (A Randomised Trial In Screening To Improve Cytology) trial
originally reported after two rounds of primary cervical screening with human papillomavirus …

Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an …

MA Smith, EA Burger, A Castanon, IMCM de Kok… - Preventive …, 2021 - Elsevier
COVID-19 has disrupted cervical screening in several countries, due to a range of policy-,
health-service and participant-related factors. Using three well-established models of …

Guía de cribado del cáncer de cuello de útero en España, 2014

AT Bladé, M del Pino Saladrigues, MC Gimferrer… - Progresos de obstetricia …, 2014 - Elsevier
The policy recommends cytology-based screening every three years from 25 to 30 years of
age, followed by HPV-based screening every five years from 30 to 65 years of age (Exhibit …

Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys

EA Burger, S Sy, M Nygård, IS Kristiansen, JJ Kim - PloS one, 2014 - journals.plos.org
Background Increasingly, countries have introduced female vaccination against human
papillomavirus (HPV), causally linked to several cancers and genital warts, but few have …

Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer

EA Burger, JJ Kim, S Sy… - Clinical Infectious Diseases, 2017 - academic.oup.com
Background Although new human papillomavirus (HPV) infections can occur at all ages, the
age at which women acquire their “causal” HPV infection that develops into cervical cancer …

An overview of cervical cancer epidemiology and prevention in Scandinavia

K Pedersen, S Fogelberg… - Acta obstetricia et …, 2018 - Wiley Online Library
New technologies such as human papillomavirus (HPV) testing and vaccination necessitate
comprehensive policy analyses to optimize cervical cancer prevention. To inform future …